“Unveiling the Heartwarming Outcome of BriaCell Therapeutics Corp’s Shareholder Meeting in 2025”
Welcome to the Future of Cancer Care On February 5, 2025, BriaCell Therapeutics Corp. announced the exciting results of its annual general meeting of shareholders. This clinical-stage biotechnology company is dedicated to developing novel immunotherapies that are set to revolutionize the way we treat cancer. A Year of Progress and Achievements At the meeting, a…